CBUS Stock Analysis: Buy, Sell, or Hold?
CBUS - Cibus, Inc. Class A Common Stock
$1.39
-0.03 (-2.11%)
▼
5d:
+3.73%
30d:
+0.0%
90d:
-27.98%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When CBUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CBUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: CBUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: CBUS is currently trading at $1.39, which is considered slightly high relative to its 30-day fair value range of $1.27 to $1.43.
Technical Outlook: Technically, CBUS is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.51.
Market Sentiment: CBUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.67 (+955.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CBUS is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.51.
Market Sentiment: CBUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.67 (+955.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.27 -
$1.43
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 955.2% below Wall St target ($14.67)
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.43
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.51
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.21
Wall Street Target
$14.67
(+955.2%)
Revenue Growth (YoY)
62.6%
Share & Embed Analysis
Last updated: July 05, 2026 1:05 PM ET
Data refreshes hourly during market hours. Next update: 2:05 PM
Data refreshes hourly during market hours. Next update: 2:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
